Clinical Trials Sponsored by The Philadelphia & South Jersey Hand Center

Total 219 results

The Philadelphia & South Jersey Hand Center

Unknown

Treatment of Trigger Finger With Steroid Injection Versus Steroid Injection and Splinting

Trigger Finger | Stenosing Tenosynovitis

United States
Temple University
The School District of Philadelphia; United Way of Greater Philadelphia and... and other collaborators

Completed

A Randomized Controlled Trial of Trauma-awareness Training for Early Childhood Educators

Burnout, Professional

United States
Memorial Sloan Kettering Cancer Center
Sanofi; Rutgers, The State University of New Jersey; University of Medicine and...

Completed

Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer

Rectal Cancer | Colon Cancer

United States
University of Medicine and Dentistry of New Jersey
Bristol-Myers Squibb; Rutgers Cancer Institute of New Jersey

Terminated

First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients

Colorectal Cancer

United States
Elucid Bioimaging Inc.
Medical University of South Carolina; The Christ Hospital; Mie University; St....

Completed

Elucidate Vasodilatory Capacity From Histology-Defined Analysis of Coronary CT Angiography (HD-FFRct)

Vascular Diseases
University of Medicine and Dentistry of New Jersey
Centers for Medicare and Medicaid Services

Completed

Addressing Disparities in Cancer Care for Latino Medicare Beneficiaries

Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer

Prostate Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer

Lung Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Withdrawn

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent... and other conditions

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Withdrawn

Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin

Carcinoma of Unknown Primary

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer

Cervical Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer

Prostate Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Sulindac and Plant Compounds in Preventing Colon Cancer

Colorectal Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Kidney Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Prostate Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer

Pancreatic Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer

Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer

Prostate Cancer | Osteoporosis

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Internet Use Among Women With Recurrent Metastatic Breast Cancer

Breast Cancer

United States
Rutgers, The State University of New Jersey
Centers for Disease Control and Prevention

Completed

Experimentally Testing the Effectiveness of a Campus-based Bystander Intervention

Violence | Helping Behavior | Sexual Assault and Rape | Assaultive Behavior

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Withdrawn

Collecting and Storing Blood Samples From Patients With Cancer

Lymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Nonmalignant Neoplasm | Lymphoproliferative Disorder and other conditions
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation

Lymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease

Lymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Dextromethorphan in Treating Patients With Fatigue Caused by Cancer

Unspecified Childhood Solid Tumor, Protocol Specific | Fatigue | Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Precancerous/Nonmalignant Condition

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Melanoma (Skin)

United States
Christian Hinrichs
National Cancer Institute (NCI); Cancer Immunology and Metabolism Center of...

Recruiting

KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

Cervical Cancer | Breast Cancer | Gastric Cancer | Lung Cancer

United States
University of Medicine and Dentistry of New Jersey
Robert Wood Johnson Foundation; Rutgers Cancer Institute of New Jersey

Completed

Combination Medications vs. Patch Alone for Medically-Ill Smokers

Smoking Cessation

United States
University of Medicine and Dentistry of New Jersey
National Center for Complementary and Integrative Health (NCCIH)

Completed

Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders

Autism

United States
Children's Hospital of Philadelphia
The Leukemia and Lymphoma Society; National Childhood Cancer Foundation

Terminated

Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma

Lymphoma | Leukemia

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI); Sanofi

Withdrawn

Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia

Hyperglycemia | Leukemia

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI); Novartis Pharmaceuticals

Completed

Phase I Study of Patupilone and RAD001

Refractory Malignancy

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI); Aventis Pharmaceuticals

Terminated

Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer

Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI); Aventis Pharmaceuticals

Terminated

Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

United States
Griffin Hospital
Centers for Disease Control and Prevention; The Hershey Company

Completed

Cocoa and Endothelial Function in Adults With Elevated BMI (Chocolate)

Cardioprotection

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI); Genentech, Inc.; Schering-Plough

Withdrawn

QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC

Lung Cancer | Metastatic Cancer
The Hospital for Sick Children
SickKids Foundation; The Cundill Centre for Child and Youth Depression

Unknown

Focused Suicide Prevention Strategy for Youth (FSPS)

Suicidal Ideation | Suicide, Attempted | Suicide

Canada
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; University... and other collaborators

Recruiting

Bright IDEAS - Young Adults Problem-Solving Skills Training

Cancer Patients | Supportive Care | Young Adult

United States
Dana-Farber Cancer Institute
The Comprehensive and Integrative Medicine Institute of South Korea

Active, not recruiting

Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled Trial

Breast Cancer

United States
Dana-Farber Cancer Institute
The Comprehensive and Integrative Medicine Institute of South Korea

Recruiting

Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial) (PACT)

Breast Cancer Stage I | Breast Cancer Stage II | Acupuncture | Breast Cancer Stage III | Chemotherapy-induced Peripheral Neuropathy | Early-stage Breast Cancer

United States
Dana-Farber Cancer Institute
The Comprehensive and Integrative Medicine Institute of South Korea

Completed

A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients

Stage I Breast Cancer | Stage II Breast Cancer | Early-Stage Breast Carcinoma | Stage III Breast Cancer | Chemotherapy-induced Peripheral Neuropathy (CIPN) | Taxane-induced Peripheral Neuropathy

United States
Wills Eye
Centers for Disease Control and Prevention; Westat; Public Health Management... and other collaborators

Completed

Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

Ocular Hypertension | Glaucoma | Macular Degeneration | Diabetic Retinopathy | Central Retinal Vein Occlusion | Cataract | Branch Retinal Vein Occlusion | Glaucoma Suspect | Central Retinal Artery Occlusion | Drusen | Branch Retinal Arterial Occlusion | Epi-retinal Membrane | Loss of Vision

United States
Rutgers, The State University of New Jersey
The University of Texas Health Science Center at San Antonio; Health Resources...

Completed

Remote Ischemic Preconditioning in Neurological Death Organ Donors (RIPNOD)

Organ Transplantation

United States
University of Oklahoma
Milton S. Hershey Medical Center; Oklahoma Center for the Advancement of Science...

Completed

Exercise for Women With Peripheral Arterial Disease

Peripheral Artery Disease | Claudication | Women

United States

Clinical Trials Sponsored by The Philadelphia & South Jersey Hand Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations